EMAGIN CORPORATION (EMAN) Stock Fundamental Analysis

NYSEARCA:EMAN • US29076N2062

2.07 USD
+0.06 (+2.99%)
At close: Oct 17, 2023
2.07 USD
0 (0%)
After Hours: 10/17/2023, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, EMAN scores 1 out of 10 in our fundamental rating. EMAN was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. EMAN has a bad profitability rating. Also its financial health evaluation is rather negative. EMAN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • EMAN had negative earnings in the past year.
  • In the past year EMAN has reported a negative cash flow from operations.
EMAN Yearly Net Income VS EBIT VS OCF VS FCFEMAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M -20M

1.2 Ratios

  • EMAN has a worse Return On Assets (-18.20%) than 83.02% of its industry peers.
  • The Return On Equity of EMAN (-114.25%) is worse than 88.68% of its industry peers.
Industry RankSector Rank
ROA -18.2%
ROE -114.25%
ROIC N/A
ROA(3y)-11.89%
ROA(5y)-17.55%
ROE(3y)-34.55%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
EMAN Yearly ROA, ROE, ROICEMAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60

1.3 Margins

  • With a Gross Margin value of 26.24%, EMAN is not doing good in the industry: 80.19% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of EMAN has grown nicely.
  • EMAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.34%
GM growth 5Y7.77%
EMAN Yearly Profit, Operating, Gross MarginsEMAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • EMAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EMAN has more shares outstanding than it did 1 year ago.
  • EMAN has a better debt/assets ratio than last year.
EMAN Yearly Shares OutstandingEMAN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EMAN Yearly Total Debt VS Total AssetsEMAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

  • EMAN has an Altman-Z score of -3.59. This is a bad value and indicates that EMAN is not financially healthy and even has some risk of bankruptcy.
  • EMAN has a Altman-Z score of -3.59. This is amonst the worse of the industry: EMAN underperforms 81.13% of its industry peers.
  • EMAN has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
  • EMAN has a worse Debt to Equity ratio (1.59) than 87.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z -3.59
ROIC/WACCN/A
WACC12.71%
EMAN Yearly LT Debt VS Equity VS FCFEMAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

2.3 Liquidity

  • EMAN has a Current Ratio of 2.06. This indicates that EMAN is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of EMAN (2.06) is worse than 75.47% of its industry peers.
  • EMAN has a Quick Ratio of 1.16. This is a normal value and indicates that EMAN is financially healthy and should not expect problems in meeting its short term obligations.
  • EMAN has a Quick ratio of 1.16. This is amonst the worse of the industry: EMAN underperforms 81.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.16
EMAN Yearly Current Assets VS Current LiabilitesEMAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for EMAN have decreased strongly by -650.00% in the last year.
  • Looking at the last year, EMAN shows a small growth in Revenue. The Revenue has grown by 0.19% in the last year.
  • Measured over the past years, EMAN shows a small growth in Revenue. The Revenue has been growing by 6.74% on average per year.
EPS 1Y (TTM)-650%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-550%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y4.54%
Revenue growth 5Y6.74%
Sales Q2Q%-30.79%

3.2 Future

  • Based on estimates for the next years, EMAN will show a very negative growth in Earnings Per Share. The EPS will decrease by -177.41% on average per year.
  • EMAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.91% yearly.
EPS Next Y-1648.97%
EPS Next 2Y-177.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.5%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EMAN Yearly Revenue VS EstimatesEMAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EMAN Yearly EPS VS EstimatesEMAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • EMAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EMAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMAN Price Earnings VS Forward Price EarningsEMAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMAN Per share dataEMAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

  • EMAN's earnings are expected to decrease with -177.41% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-177.41%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for EMAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EMAGIN CORPORATION

NYSEARCA:EMAN (10/17/2023, 8:04:00 PM)

After market: 2.07 0 (0%)

2.07

+0.06 (+2.99%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-10
Earnings (Next)11-08
Inst Owners0.75%
Inst Owner Change0%
Ins Owners0.12%
Ins Owner Change0%
Market Cap172.20M
Revenue(TTM)27.56M
Net Income(TTM)-13.32M
Analysts82.5
Price Target3.06 (47.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-210.46%
Min EPS beat(2)-324.84%
Max EPS beat(2)-96.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.35%
Min Revenue beat(2)-30.23%
Max Revenue beat(2)-14.46%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60%
EPS NY rev (1m)0%
EPS NY rev (3m)-138.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.25
P/FCF N/A
P/OCF N/A
P/B 14.77
P/tB 14.81
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.33
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.2%
ROE -114.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.24%
FCFM N/A
ROA(3y)-11.89%
ROA(5y)-17.55%
ROE(3y)-34.55%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.34%
GM growth 5Y7.77%
F-Score2
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 583.49%
Cap/Sales 56.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.16
Altman-Z -3.59
F-Score2
WACC12.71%
ROIC/WACCN/A
Cap/Depr(3y)406.79%
Cap/Depr(5y)278.01%
Cap/Sales(3y)39.01%
Cap/Sales(5y)25.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-650%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-550%
EPS Next Y-1648.97%
EPS Next 2Y-177.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.19%
Revenue growth 3Y4.54%
Revenue growth 5Y6.74%
Sales Q2Q%-30.79%
Revenue Next Year-25.5%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-196.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.32%
OCF growth 3YN/A
OCF growth 5YN/A

EMAGIN CORPORATION / EMAN FAQ

Can you provide the ChartMill fundamental rating for EMAGIN CORPORATION?

ChartMill assigns a fundamental rating of 1 / 10 to EMAN.


What is the valuation status for EMAN stock?

ChartMill assigns a valuation rating of 0 / 10 to EMAGIN CORPORATION (EMAN). This can be considered as Overvalued.


What is the profitability of EMAN stock?

EMAGIN CORPORATION (EMAN) has a profitability rating of 1 / 10.